TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Paul Martingell
VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm

Virbac has acquired an innovative drug from Norbrook to treat feline hyperthyroidism, valued at £100 million. The product will be distributed under Thyronorm and Felanorm brands across multiple countries, targeting a growing market of senior cats with this common endocrine disease.

Insights
MSpQ   neutral

Standard financial transaction of acquiring minority stake without indicating positive or negative strategic implications


VBACY   positive

Expanding product portfolio, acquiring innovative drug, demonstrating strategic growth and commitment to animal health